Pancreatic cancer: Update on immunotherapies and algenpantucel-L

Pancreatic adenocarcinoma is notoriously lethal, and despite improvements in systemic chemotherapy approaches bringing survival rates for metastatic disease to almost 1 year, by 2030 it is expected to become the second leading cause of cancer death. Pancreatic cancer (PC) prognosis has been associat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: McCormick, Kinsey A., Coveler, Andrew L., Rossi, Gabriela R., Vahanian, Nicholas N., Link, Charles, Chiorean, E. Gabriela
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2015
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964650/
https://ncbi.nlm.nih.gov/pubmed/26619245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1093264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars